Liquidia Corp Industry Peers
Companies in the Pharmaceuticals industry
Key Data Points
- Altman Z-Score -1.26 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Pharmaceuticals
177 companies in this industry (including LQDA)
Sector: Health Care
Other Companies in Pharmaceuticals
| Company | Revenue | Profit Margin | ROE |
|---|---|---|---|
| Johnson & Johnson(JNJ) | $92.15B | 27.3% | 31.7% |
| Merck & Co.(MRK) | $64.23B | 29.6% | 36.7% |
| Pfizer(PFE) | $62.78B | 15.7% | 10.6% |
| Lilly (Eli)(LLY) | $59.42B | 31.0% | 77.4% |
| Bristol Myers Squibb(BMY) | $48.03B | 12.6% | 32.6% |
| TEVA PHARMACEUTICAL INDUSTRIES LTD(TEVA) | $16.54B | -9.9% | - |
| Viatris(VTRS) | $14.74B | -4.3% | - |
| Bausch Health Companies Inc.(BHC) | $10.03B | 3.6% | - |
| Zoetis(ZTS) | $9.40B | 28.2% | 49.1% |
| Organon & Co.(OGN) | $6.30B | 8.0% | 55.3% |
| Elanco(ELAN) | $4.59B | 0.8% | 0.5% |
| Perrigo(PRGO) | $4.28B | -1.2% | -1.2% |
| Jazz Pharmaceuticals(JAZZ) | $4.16B | -8.9% | -9.3% |
| BeOne Medicines Ltd.(ONC) | $3.81B | -16.9% | - |
| Amneal Pharmaceuticals, Inc.(AMRX) | $2.93B | 1.7% | - |
| Royalty Pharma plc(RPRX) | $2.26B | 38.0% | - |
| ALNYLAM PHARMACEUTICALS, INC.(ALNY) | $2.25B | -12.4% | - |
| Alkermes plc(ALKS) | $1.52B | 22.3% | 19.6% |
| Phibro Animal Health(PAHC) | $1.30B | 3.7% | - |
| Indivior(INDV) | $1.18B | 10.4% | - |
Data source: SEC EDGAR filings. Financial data may be from the most recent fiscal year.